Evidence map›Paper›PMID 32728799›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2021

E Guedj, M Million, P Dudouet, H Tissot-Dupont, F Bregeon, S Cammilleri, D Raoult

Registry-linked trialOpen access · bronzeAbstract readCase Reports
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05009563 (Evaluation of COVID-19 by Whole-body FDG-PET/CT), which is not on this map. Cited by 89 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 6 pooled it
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05009563 naunknown statusnot on this map

Evaluation of COVID-19 by Whole-body FDG-PET/CT

TypeinterventionalSponsorSemmelweis University Heart and Vascular CenterRan2021 to 2022Enrolled50ConditionsCoronavirus InfectionArmsFDG-PET/CT
3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 6 syntheses or guidelines pooled it, 192 citations in OpenAlex.

  1. Pooled it
  2. Molecular Imaging Findings on Acute and Long-Term Effects of COVID-19 on the Brain: A Systematic Review.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. medRxiv : the preprint server for health sciences · 2024
    Article
  18. Article
  19. Article
  20. Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

E GuedjNuclear Medicine Department, Aix Marseille University, APHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, CERIMED, 264 rue Saint Pierre, 13005, Marseille, France. eric.guedj@ap-hm.fr.ORCID 0000-0003-1912-6132
M MillionIHU-Méditerranée Infection, Marseille, France.
P DudouetIHU-Méditerranée Infection, Marseille, France.
H Tissot-DupontIHU-Méditerranée Infection, Marseille, France.
F BregeonIHU-Méditerranée Infection, Marseille, France.
S CammilleriNuclear Medicine Department, Aix Marseille University, APHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, CERIMED, 264 rue Saint Pierre, 13005, Marseille, France.
D RaoultIHU-Méditerranée Infection, Marseille, France.
Aix-Marseille Université · FRCentre National de la Recherche Scientifique · FRMéditerranée Infection Foundation · FR

Funding

APHM PHRC régional
6 · The paper itself

Abstract

purposeSeveral brain complications of SARS-CoV-2 infection have been reported. It has been moreover speculated that this neurotropism could potentially cause a delayed outbreak of neuropsychiatric and neurodegenerative diseases of neuroinflammatory origin. A propagation mechanism has been proposed across the cribriform plate of the ethmoid bone, from the nose to the olfactory epithelium, and possibly afterward to other limbic structures, and deeper parts of the brain including the brainstem.

methodsReview of clinical examination, and whole-brain voxel-based analysis of

resultsHypometabolism of the olfactory/rectus gyrus was found on the two patients, especially one with 4-week prolonged anosmia. Additional hypometabolisms were found within amygdala, hippocampus, parahippocampus, cingulate cortex, pre-/post-central gyrus, thalamus/hypothalamus, cerebellum, pons, and medulla in the other patient who complained of delayed onset of a painful syndrome.

conclusionThese preliminary findings reinforce the hypotheses of SARS-CoV-2 neurotropism through the olfactory bulb and the possible extension of this impairment to other brain structures.

Indexed as

Positron-Emission TomographyAnosmiaBrainCOVID-19Fluorodeoxyglucose F18HumansMaleMiddle AgedPainPost-Acute COVID-19 SyndromeRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticals18F-FDG-PETAnosmiaBrainstemCOVID-19Functional disordersLimbic systemSARS-CoV-2

Identifiers

PMID32728799
PMCPMC7391029
OpenAlexW3045998806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.